Legislators
Bills
Statements
Lobbying
Travel
Searching...- Lobbying
- Lobbying by Amgen USA Inc.
Lobbying Relationship
Bills mentioned
S.3187: Food and Drug Administration Safety and Innovation Act
Sponsor: Tom Harkin (D-Iowa)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
| Lobbyist | Covered positions? |
|---|---|
| Steve Symm | U.S. Senator: 1981 - 1993 |
| Thaddeus Strom | Chief Counsel, Sen. Strom Thurmond: 1987 to 1988 Gen. Coun./Staff Dir., Sen. Cmte. on the Judciary: 1988-1991 Chief Coun/Staff Dir, Sen Cmte on the Judiciary:1991-1993 ChfCoun/StfDir, SenCmteonAntitrust,BusRghts,Etc: 1994-1997 |
| Edward Baxter | Chief Counsel and Staff Director, Senate Judiciary Committee's Subcommittee on Patents, Copyrights and Trademarks: 1987 to 1990 |
| James Rock | Staff Asst., U.S. House Committee on Budget: 1985 to 2000 |
| Romano Romani | n/a |
| Steve Symms | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate